$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
瑞格非尼(Regorafenib)肝癌靶向药物
2025-10-19 11:44:20
Check Details
多吉美适应于晚期无法手术的肝癌患者
2025-10-19 11:44:20
Check Details
卡博替尼适应症之肝癌
2025-10-19 11:44:20
Check Details
索拉菲尼作用机制说明
2025-10-19 11:44:20
Check Details
多吉美抗肿瘤治疗之肝癌
2025-10-19 11:44:20
Check Details
多吉美抗肿瘤治疗的总结
2025-10-19 11:44:20
Check Details
舒尼替尼临床研究之肝癌
2025-10-19 11:44:20
Check Details
索拉菲尼在进展期原发性肝癌中的应用
2025-10-19 11:44:20
Check Details
索拉菲尼治疗原发性肝癌作用机制之阻断RAF激酶
2025-10-19 11:44:20
Check Details
索拉菲尼治疗原发性肝癌作用机制之抑制肿瘤血管发生
2025-10-19 11:44:20
Check Details
索拉非尼治疗肝细胞癌国际研究:第二次中期分析
2025-10-19 11:44:20
Check Details
乐伐替尼的慎用人群
2025-10-19 11:44:20
Check Details
1
2
...
8618
8619
8620
8621
8622
8623
8624
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
2
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
3
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
4
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
5
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
6
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
7
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
8
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
9
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
10
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
11
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
12
Complete Guide to Dosage and Dose Adjustment of Entrectinib